Saku Torvinen, PhD

Saku Torvinen, PhD, has extensive experience in market access and public policy in the pharmaceutical industry. Saku began their career at Nycomed (Leiras Finland) as a Health Economic and Pharma Market Analyst, where they were responsible for market access-related topics and producing market analyses. Saku then joined GlaxoSmithKline as a Health Economics Manager, leading various health economics and market access issues, launching oncological assets, and supporting pricing negotiations. After that, Torvinen became the Head of Health Economics, Pricing & Reimbursement at GlaxoSmithKline, where they led the Health Economic/Market Access team and supported new product introduction, pricing strategy, and government affairs activities. Saku also served as the Health Outcomes Manager for North & West Europe at GlaxoSmithKline, taking responsibility for market access and value demonstration strategies for multiple therapeutic areas. Torvinen later joined Teva Europe as the Director of Pricing & Market Access Europe, leading the respiratory pricing and market access team and launching products for European and global markets. Most recently, they have been working at Takeda, where they held various roles including Director of Market Access & External Affairs for Finland & Baltics, IBD Business Unit Director for Finland & Baltics, and Head of Patient Value and Access & Public Policy. In these roles, Torvinen was responsible for market access, patient relations, communications, and public policy, launched products in oncology and rare diseases, and created value-based solutions. Saku has demonstrated strong business acumen and leadership skills throughout their career.

Saku Torvinen, PhD has an education history that includes a Master's degree in Health Economics from the University of Eastern Finland, which was completed in 2002. Following this, they pursued a PhD in Medicine at the University of Helsinki, which was completed in 2019.